News

Expand filters

Filters

Services

Locations

Showing 91 - 100 out of 186 results

News

BJC Health System Receives National Recognition for LGBTQ+ Equality and Inclusion

Multiple hospitals earned high marks as Healthcare Equality Leader and High Performer designations.

News

FOX4: Benefits of Intermittent Fasting

Dr. James O'Keefe, preventive cardiologist with Saint Luke's Mid America Heart Institute, joins FOX4 to talk about what it is, the pros and cons of intermittent fasting, and who would benefit from it most.

Article

American Heart Association: Anger's Role in Heart Attack Risk May Start in the Arteries

Dr. Suzanne Arnold weighs in on new findings that may help explain how anger contributes to the risk of having a heart attack.

Article

Consumer Reports On Health: Enjoy Life, Even with Heart Failure

Consumer Reports On Health talked to Dr. Bethany Austin and Austin Workman about strategies to improve quality of life for those living with heart failure.

Article

Double the Teamwork

Kelly Anspaugh received both a heart and kidney transplant at Saint Luke's.

Article

AARP: 10 Types of Exercise That Can Help You Live Longer

AARP talked to Dr. James O'Keefe about different types of exercise that can help improve longevity.

News

U.S. News & World Report: Wegovy Helps Those With Both Diabetes, Heart Failure: Study

For people struggling with both diabetes and a common type of heart failure, the weight-loss drug Wegovy may do more for their health than help them shed pounds, new research suggests.

News

CNN: Weight-Loss Drug Wegovy Offers Benefits for People with Diabetes and Common Form of Heart Failure, Study Finds

The popular weight loss drug Wegovy seems to provide more health benefits for people who have diabetes and a common kind of heart failure than just helping take off the pounds, according to the results from the STEP HFpEF DM trial.

News

Good Morning America: New Report on the Effect of Weight Loss Drugs on Heart Disease

A new study led by Dr. Mikhail Kosiborod found patients with obesity-related heart failure and diabetes had a significant improvement in symptoms when taking semaglutide.

Press Release

MEDIA COVERAGE: Obesity Medication Proves Effective in Treating Patients with Obesity-Related Heart Failure and Type 2 Diabetes

A new study led by Dr. Mikhail Kosiborod found patients with obesity-related heart failure and type 2 diabetes had significant improvement in symptoms and physical limitations when taking semaglutide.